News

Zacks Investment Research on MSN5h
Novo Nordisk Plunges 17% in a Month: Buy, Sell or Hold the Stock?
Novo Nordisk NVO shares have lost 16.7%, attributable to both sector-specific developments and broader macroeconomic ...
Could Novo Nordisk's Wegovy-fuelled run of hiking sales guidance be ending?
STORY: Since launching its popular weight-loss drug Wegovy in 2021, Novo Nordisk has raised its annual sales guidance several ...
Novo Nordisk's stellar Wegovy-fuelled run of hiking sales guidance could be ending
Since launching its wildly popular weight-loss drug Wegovy in 2021, Novo Nordisk has raised its annual sales guidance several ...